This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Ohlhausen says Steris-Synergy decision should give FTC pause when considering potential competition cases

By Liz Crampton ( January 27, 2016, 20:22 GMT | Insight) -- The victory of Steris and Synergy Health in a court fight with the US Federal Trade Commission over the companies’ proposed merger should cause the agency to be careful in pursuing cases based on potential competition, FTC Commissioner Maureen Ohlhausen said in a speech at an antitrust conference.The victory of Steris and Synergy Health in a court fight with the US Federal Trade Commission over the companies’ proposed merger should cause the agency to be careful in pursuing cases based on potential competition, FTC Commissioner Maureen Ohlhausen said....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login